Today, the Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest launched Ignite, its new funding program to support Canadian innovators designing solutions for older persons.
Genentech gets gluey, paying $47M upfront to Orionis for degrader discovery deal
In its second deal announced Wednesday morning, Roche’s Genentech is signing up with Orionis Biosciences for a molecular glue partnership in cancer and neurodegeneration. Genentech